2.05 USD
↗ 0.05 (2.50%)AT CLOSE (03:59 PM EDT)
Foghorn Therapeutics Inc. Common Stock
FHTXNASDAQ • USD
2.00
↘ 0.05 (2.68%)
POST MARKET (AS OF 07:59 PM EDT)
Post Market
AS OF 07:59 PM EDT
2.00
↘ 0.05 (2.68%)
Market: CLOSED
Foghorn Therapeutics Inc. Common Stock (FHTX) trades at $2.05 per share. Both sides of the analysis point lower: technicals flash "Sell" and fundamentals confirm with a "Sell" reading. Notable factors include a concerning Altman Z-Score in the distress zone, exceptional Return on Equity (79.7%), a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.
Technical & fundamental data as of Oct 26, 2026.
Open?$1.99
High?$2.06
Low?$1.93
Prev. Close?$2.00
Volume?509.7K
Avg. Volume?1.1M
VWAP?$2.02
Rel. Volume?0.45x
Bid / Ask
Bid?$1.85 × 200
Ask?$2.10 × 100
Spread?$0.25
Midpoint?$1.98
Valuation & Ratios
Market Cap?121.7M
Shares Out?59.4M
Float?33.8M
Float %?56.9%
P/E Ratio?N/A
P/B Ratio?-1.50
EPS?-$1.09
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Foghorn Therapeutics Inc is a clinical stage, precision therapeutics biotechnology company focused on pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression through selectively targeting the chromatin regulatory system. Its proprietary platform is designed to provide an integrated, mechanistic understanding of interactions within the chromatin regulatory system, supporting the identification and validation of potential therapeutic targets. The company's flagship program is FHD-909.
Themes
Employees
106
Market Cap
118.8M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2020-10-23
Address
500 TECHNOLOGY SQUARE
CAMBRIDGE, MA 02139
Phone: 617-586-3100
CAMBRIDGE, MA 02139
Phone: 617-586-3100
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?23
Z-Score?0
Momentum?75
Short Sent.?68
Piotroski F-Score?3/9Weak
Altman Z-Score?-4.58Distress
Confidence?48%Low
Short InterestElevated
Short % of Float?7.26%Elevated
Short Interest?2.5M
Days to Cover?1.2
Free Float33.8M
Avg Daily Volume2.1M
Settlement Date2026-10-15
Financial Health
Current Ratio?3.36Strong
Quick Ratio?3.36Strong
Cash Ratio?1.35Strong
Debt/Equity?-0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score92/100
P/E?N/A▾
P/B?-1.50CHEAP▾
S&P97
P/S?3.31FAIR▾
Peers100
S&P46
P/FCF?N/A▾
EV/EBITDA?-0.8CHEAP▾
S&P97
EV/Sales?1.46CHEAP▾
Peers100
S&P84
Returns & Efficiency
ROE?79.7%STRONG▾
Peers50
S&P97
ROA?-31.8%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-84291000
Enterprise Value?$53.7M
Fundamentals ratios updated end of day